Antioxidant, Antiglaucoma, Anticholinergic, and Antidiabetic Effects of Kiwifruit (Actinidia deliciosa) Oil: Metabolite Profile Analysis Using LC-HR/MS, GC/MS and GC-FID

• Published in: Life (Basel, Switzerland) Vol. 13; no. 9; p. 1939
• Main Authors: Ozden, Eda Mehtap, Bingol, Zeynebe, Mutlu, Muzaffer, Karagecili, Hasan, Köksal, Ekrem, Goren, Ahmet C, Alwasel, Saleh H, Gulcin, İlhami
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.09.2023; MDPI
• Subjects: Acetylcholinesterase; Acids; Actinidia; Actinidia deliciosa; Alzheimer's disease; Amylases; Anticholinergics; Antidiabetics; antioxidant activity; Antioxidants; Brinzolamide; Carbonic anhydrase; Carbonic anhydrase II; Caryophyllene; Caryophyllene oxide; Chemical composition; Chemical properties; Chemicals; Copper; Diabetes; Diabetes mellitus; Enzymes; Essences and essential oils; Essential oils; Free radicals; Fruits; Gas chromatography; GC-MS; Glaucoma; Glucose; Health aspects; Herbal medicine; Hyperglycemia; Hypoglycemic agents; Insulin resistance; Iron; Kiwifruit; kiwifruit oil; LC-HRMS; Linoleic acid; Mass spectrometry; Medicinal plants; Metabolism; Metabolites; Ophthalmic drugs; Oxidative stress; Palmitic acid; Parasympatholytic agents; Pharmaceutical research; Phenolic compounds; Phenols; Plant metabolites; polyphenol; Polyphenols; Scavenging; Scientific equipment and supplies industry; Squalene; Sulfonic acid; Triazine; α-Amylase; United States; Germany; Turkey
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life13091939

Determining the antioxidant abilities and enzyme inhibition profiles of medicinally important plants and their oils is of great importance for a healthy life and the treatment of some common global diseases. Kiwifruit (Actinidia deliciosa) oil was examined and researched using several bioanalytical methods comprehensively for the first time in this research to determine its antioxidant, antiglaucoma, antidiabetic and anti-Alzheimer’s capabilities. Additionally, the kiwifruit oil inhibitory effects on acetylcholinesterase (AChE), carbonic anhydrase II (CA II), and α-amylase, which are linked to a number of metabolic illnesses, were established. Furthermore, LC-HRMS analysis was used to assess the phenolic content of kiwifruit oil. It came to light that kiwifruit oil contained 26 different phenolic compounds. According to the LC-HRMS findings, kiwifruit oil is abundant in apigenin (74.24 mg/L oil), epigallocatechin (12.89 mg/L oil), caryophyllene oxide (12.89 mg/L oil), and luteolin (5.49 mg/L oil). In addition, GC-MS and GC-FID studies were used to ascertain the quantity and chemical composition of the essential oils contained in kiwifruit oil. Squalene (53.04%), linoleoyl chloride (20.28%), linoleic acid (2.67%), and palmitic acid (1.54%) were the most abundant compounds in kiwifruit oil. For radical scavenging activities of kiwifruit oil, 1,1-diphenyl-2-picryl-hydrazil (DPPH•) and 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS•+) radicals scavenging techniques were examined. These methods effectively demonstrated the potent radical scavenging properties of kiwifruit oil (IC50: 48.55 μg/mL for DPPH•, and IC50: 77.00 μg/mL for ABTS•+ scavenging). Also, for reducing capabilities, iron (Fe3+), copper (Cu2+), and Fe3+-2,4,6-tri(2-pyridyl)-S-triazine (TPTZ) reducing abilities were studied. Moreover, kiwifruit oil showed a considerable inhibition effect towards hCA II (IC50: 505.83 μg/mL), AChE (IC50: 12.80 μg/mL), and α-amylase (IC50: 421.02 μg/mL). The results revealed that the use of kiwifruit oil in a pharmaceutical procedure has very important effects due to its antioxidant, anti-Alzheimer, antidiabetic, and antiglaucoma effects.